Targeting v&bgr;3 Integrin: Design and Applications of Mono- and Multifunctional RGD-Based Peptides and Semipeptides

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|13|1255-1299

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.13, 2010-05, pp. : 1255-1299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multimodality Imaging of Tumor Integrin v&bgr;3 Expression

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in amp;#945;(v)amp;#946;(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides

By  

Current Radiopharmaceuticals, Vol. 2, Iss. 3, 2009-07 ,pp. : 214-219

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers

By  

Current Medicinal Chemistry, Vol. 19, Iss. 20, 2012-07 ,pp. : 3301-3309

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of V&bgr;7.1_H3F7 as a Therapeutic Gene Encoding TCR Specific to Hepatocellular Carcinoma

By  

Current Gene Therapy, Vol. 14, Iss. 5, 2014-10 ,pp. : 389-399

Bentham Science Publishers

Access to resources Recommend Favorite

Ligands to the integrin receptor v&bgr;3

By Duggan M.E.   Hutchinson J.H.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1367-1383

Informa Healthcare

Access to resources Recommend Favorite